{"transactions":[{"id":701478,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":28028,"kind":"person","name":"Johnson Karen Marie","position":1,"cik":"0001892819","reported_name":"Johnson Karen Marie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-29T22:46:17.000Z","date":"2026-07-27","kind":"grant","planned":false,"acquired":true,"shares":31124,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents grant of restricted stock units (RSUs), each of which entitle the Reporting Person to receive one share of the Issuer's common stock upon settlement. The RSUs vest in full on the date of the Issuer's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on the vesting date."}],"balance_after":319410,"source":{"system":"sec-edgar","filing":"0001079973-26-000981","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000107997326000981/ownership.xml","form_type":"4"}},{"id":990202,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":28028,"kind":"person","name":"Johnson Karen Marie","position":1,"cik":"0001892819","reported_name":"Johnson Karen Marie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-24T22:21:35.000Z","date":"2025-11-20","kind":"grant","planned":false,"acquired":true,"shares":37037,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents restricted stock units that were fully vested upon grant."}],"balance_after":288286,"source":{"system":"sec-edgar","filing":"0001553350-25-000145","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000155335025000145/ownership.xml","form_type":"4"}},{"id":990201,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":28028,"kind":"person","name":"Johnson Karen Marie","position":1,"cik":"0001892819","reported_name":"Johnson Karen Marie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-11-24T22:21:35.000Z","date":"2025-11-20","kind":"grant","planned":false,"acquired":true,"shares":47840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in full on Issuer's 2026 annual stockholder meeting date, subject to continued service with the Issuer through such vesting date."}],"balance_after":251249,"source":{"system":"sec-edgar","filing":"0001553350-25-000145","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000155335025000145/ownership.xml","form_type":"4"}},{"id":1188874,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":28028,"kind":"person","name":"Johnson Karen Marie","position":1,"cik":"0001892819","reported_name":"Johnson Karen Marie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Warrant","published_at":"2025-03-28T21:36:36.000Z","date":"2025-03-26","kind":"purchase","planned":false,"acquired":true,"shares":18112,"price":0.125,"value":2264.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents securities purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated March 24, 2025 (the \"Private Placement\"). Pursuant to the terms of the Securities Purchase Agreement, the Company issued the reporting person Private Placement units consisting of two shares of the Company's common stock (\"Common Stock\") and a common warrant (\"Common Warrant\") to purchase one share of Common Stock (the \"Private Placement Unit\")."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents securities purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated March 24, 2025 (the \"Private Placement\"). Pursuant to the terms of the Securities Purchase Agreement, the Company issued the reporting person Private Placement units consisting of two shares of the Company's common stock (\"Common Stock\") and a common warrant (\"Common Warrant\") to purchase one share of Common Stock (the \"Private Placement Unit\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The issuance of the securities to the reporting person pursuant to the Private Placement was approved by the Company's board of directors and was deemed an exempt transaction pursuant to Rule 16b-3 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each Private Placement Unit was purchased at a price of $2.2084 per unit, with a cost per share of Common Stock of $1.0417 and a cost per Common Warrant of $0.1250."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reporting person may not exercise any portion of a Common Warrant to the extent that the reporting person would beneficially own more than 4.99% of the number of shares of Common Stock outstanding immediately prior to or after giving effect to such exercise, as such percentage ownership is determined in accordance with Section 13(d) under the Exchange Act."}],"balance_after":18112,"derivative":{"exercise_price":1.198,"exercise_date":"2025-03-26","expiration_date":"2030-03-26","underlying":"Common Stock","underlying_shares":18112},"source":{"system":"sec-edgar","filing":"0001079973-25-000523","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000107997325000523/ownership.xml","form_type":"4"}},{"id":1188873,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":28028,"kind":"person","name":"Johnson Karen Marie","position":1,"cik":"0001892819","reported_name":"Johnson Karen Marie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-03-28T21:36:36.000Z","date":"2025-03-26","kind":"purchase","planned":false,"acquired":true,"shares":36224,"price":1.0417,"value":37734.5408,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents securities purchased in a private placement transaction directly from the Company pursuant to a Securities Purchase Agreement, dated March 24, 2025 (the \"Private Placement\"). Pursuant to the terms of the Securities Purchase Agreement, the Company issued the reporting person Private Placement units consisting of two shares of the Company's common stock (\"Common Stock\") and a common warrant (\"Common Warrant\") to purchase one share of Common Stock (the \"Private Placement Unit\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The issuance of the securities to the reporting person pursuant to the Private Placement was approved by the Company's board of directors and was deemed an exempt transaction pursuant to Rule 16b-3 of the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each Private Placement Unit was purchased at a price of $2.2084 per unit, with a cost per share of Common Stock of $1.0417 and a cost per Common Warrant of $0.1250."}],"balance_after":203409,"source":{"system":"sec-edgar","filing":"0001079973-25-000523","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000107997325000523/ownership.xml","form_type":"4"}},{"id":1352802,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":28028,"kind":"person","name":"Johnson Karen Marie","position":1,"cik":"0001892819","reported_name":"Johnson Karen Marie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2024-11-25T21:26:37.000Z","date":"2024-11-22","kind":"grant","planned":false,"acquired":true,"shares":52000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in full on TOI, Inc.'s 2025 annual shareholder meeting date, subject to continued service with the Company through such vesting date."}],"balance_after":167185,"source":{"system":"sec-edgar","filing":"0001799191-24-000055","document":"wk-form4_1732569990.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000179919124000055/wk-form4_1732569990.xml","form_type":"4"}},{"id":1698738,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":28028,"kind":"person","name":"Johnson Karen Marie","position":1,"cik":"0001892819","reported_name":"Johnson Karen Marie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2023-12-28T22:38:32.000Z","date":"2023-12-26","kind":"grant","planned":false,"acquired":true,"shares":52000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units that vest in full on TOI, Inc. 2024 annual shareholder meeting date, subject to continued service with the Company through such vesting date."}],"balance_after":115185,"source":{"system":"sec-edgar","filing":"0001628280-23-042826","document":"wk-form4_1703803101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000162828023042826/wk-form4_1703803101.xml","form_type":"4"}},{"id":1943158,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":28028,"kind":"person","name":"Johnson Karen Marie","position":1,"cik":"0001892819","reported_name":"Johnson Karen Marie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2023-03-22T00:45:16.000Z","date":"2023-03-17","kind":"grant","planned":false,"acquired":true,"shares":19685,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in full on March 16, 2024, subject to continued service with the Company through such vesting date."}],"balance_after":63185,"source":{"system":"sec-edgar","filing":"0001628280-23-008826","document":"wf-form4_167944590432914.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000162828023008826/wf-form4_167944590432914.xml","form_type":"4"}},{"id":2108723,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":28028,"kind":"person","name":"Johnson Karen Marie","position":1,"cik":"0001892819","reported_name":"Johnson Karen Marie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-11-21T22:32:12.000Z","date":"2022-11-17","kind":"grant","acquired":true,"shares":22708,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units that vest in full on May 17, 2023, subject to continued service with the Company through such vesting date."}],"balance_after":43500,"source":{"system":"sec-edgar","filing":"0001799191-22-000033","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000179919122000033/edgardoc.xml","form_type":"4"}},{"id":2320118,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":28028,"kind":"person","name":"Johnson Karen Marie","position":1,"cik":"0001892819","reported_name":"Johnson Karen Marie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2022-03-23T23:33:47.000Z","date":"2022-03-21","kind":"grant","acquired":true,"shares":4798,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":20792,"source":{"system":"sec-edgar","filing":"0001628280-22-007092","document":"wf-form4_164807841319276.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000162828022007092/wf-form4_164807841319276.xml","form_type":"4"}},{"id":2320117,"issuer":{"id":5327,"kind":"organization","name":"Starling Oncology, Inc."},"owners":[{"id":28028,"kind":"person","name":"Johnson Karen Marie","position":1,"cik":"0001892819","reported_name":"Johnson Karen Marie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock","published_at":"2022-03-23T23:33:47.000Z","date":"2022-03-21","kind":"grant","acquired":true,"shares":15994,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units that vest in full on November 12, 2022, subject to continued service with the Company through such vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents restricted stock units that vest in full on November 12, 2022, subject to continued service with the Company through such vesting date."}],"balance_after":15994,"source":{"system":"sec-edgar","filing":"0001628280-22-007092","document":"wf-form4_164807841319276.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1799191/000162828022007092/wf-form4_164807841319276.xml","form_type":"4"}}]}